Recombinant Human Active Src Protein, CF

R&D Systems | Catalog # 4595-KS

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems Sf 9 (baculovirus)-derived Recombinant Human Active Src Protein (4595-KS)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

Sf 9 (baculovirus)

Accession Number

NM_005417

Applications

Bioactivity
View all Src Proteins and Enzymes »

Product Specifications

Source

Spodoptera frugiperda, Sf 9 (baculovirus)-derived human Src protein

N-terminal Sequence Analysis

Using an N-terminal GST tag

SDS-PAGE

83 kDa

Activity

The specific activity of Src was determined to be 100 nmol/min/mg using a synthetic peptide substrate.

Scientific Data Images for Recombinant Human Active Src Protein, CF

Recombinant Human Active Src Protein SDS-PAGE

Recombinant Human Active Src Protein SDS-PAGE.

The approximate molecular weight is 83 kDa and the purity is > 90%.

Formulation, Preparation, and Storage

4595-KS
Formulation Supplied in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM Glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, and 25% Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage This product is stable at ≤ ‑70 °C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Background: Src

The Src family belongs to non-receptor tyrosine kinases. Src was originally identified as a transforming protein of the Rous Sarcoma Virus (RSV) that had the enzymatic ability to phosphorylate tyrosine in protein substrates (1). Src is over-expressed and activated in a large number of human malignancies and has been linked to the development of cancer and progression to distant metastases (2). In addition to increasing cell proliferation, a key role of Src in cancer seems to be the ability to promote invasion and motility, functions that might contribute to tumor progression.

References

  1. Collett, M.S. et al. (1978) Proc. Natl. Acad. Sci. USA 75:2021.
  2. Jacobs, C. et al. (1983) Cancer Res. 43:1696.

Long Name

v-src Sarcoma [Schmidt-Ruppin A-2] Viral Oncogene Homolog

Alternate Names

ASV, c-Src, RSVgp4

Entrez Gene IDs

6714 (Human); 20779 (Mouse); 83805 (Rat); 1491925 (Viral)

Gene Symbol

SRC

UniProt

NM_005417 (Human)

Additional Src Products

Product Documents for Recombinant Human Active Src Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Active Src Protein, CF

For research use only

Citations for Recombinant Human Active Src Protein, CF

Customer Reviews for Recombinant Human Active Src Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Active Src Protein, CF and earn rewards!

Have you used Recombinant Human Active Src Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Active Src Protein, CF (4595-KS):

Materials
  • Active Kinase - Active Src (0.1 μg/μL) diluted with Kinase Dilution Buffer X (1X). Note: These are suggested working dilutions and it is recommended that the researcher perform a serial dilution of Active Src for optimal results.
  • Kinase Assay Buffer II - Buffer components: 25 mM MOPS, pH 7.2, 12.5  beta -glycerol-phosphate, 20 mM MgC12, 12.5 mM MnC12, 2 mM EDTA. Add 0.25 mM DTT to Kinase Assay Buffer prior to use. 
  • Kinase Dilution Buffer IV - Kinase Assay Buffer II diluted at 1:4 ratio (5X dilution) with 50 ng/μL BSA solution.
  • 10 mM ATP Stock Solution- Prepare ATP stock solution by disolving 55 mg of ATP in 10 mL of Kinase Assay Buffer II. Store 200 μL aliquots of  ≤-20  °C.
  • [33P]-ATP Assay Cocktail - Prepare 250 uM [33P]-ATP Assay Cocktail in a designated radioactive area by adding the following components: 150 μL of 10 mM ATP Stock Solutions, 100 μL [33P]-ATP, 5.75 mL of Kinase Assay Buffer II.Store 200 μL aliquots of  ≤-20  °C.
  • Substrate - Src synethic peptide substrate diluted in 20 mM Tris-HCI, pH 7.5 to a final concentration of 1 mg/mL.
1. Thaw [33P]-ATP Assay Cocktail in shielded container in a designated radioactive working area.
2. Thaw the Active Src, Kinase Assay Buffer, Substrate and Kinase Dilution Buffer on ice.
3. In a pre-cooled microfuge tube, add the following reaction components bringing the initial reaction volume up to 20 μL:
a. Diluted Active Src: 10 μL
b. 1 mg/mL stock solution of substrate: 5 μL
c. Distilled water (2-4 °C) 
4. Set up the blank control as outlined in Step 3, excluding the addition of the substrate. Replace the substrate with an equal volume of distilled water.
5. Initiate the reaction by the addition of 5 μL [33P]-ATP Assay Cocktail bringing the final volume up to 25 μL and incubate the mixture in a water bath at 30 °C for 15 minutes.
6. After the 15 minute incubation period, terminate the reaction by spotting 20 μL of the reaction mixture onto individual pre-cut strips of phosphocellulose P81 paper.
7. Air dry the pre-cut P81 strip and sequentially wash in a 1% phosphoric acid solution (dilute 10 mL of phosphoric acid and make a 1L solution with distilled water) with constant gentle stirring. It is recommended that the strips be washed a total of 3 intervals for approximately 10 minutes each.
8. Count the radioactivity on the P81 paper in the presence of scintillation fluid in a scintillation counter.
9. Determine the corrected cpm by removing the blank control value (Step 4) for each sample and calculate the kinase specific activity as outlined below.
Calculation of Specific Activity of ADP (RLU/pmol)
Specific activity (SA) = cpm for 5 μL [33P]-ATP / pmoles of ATP (in 5 μL of a 250 μM ATP stock solution, i.e., 1250 pmoles)
Kinase Specific Activity (SA) (pmol/min/μg or nmol/min/mg)
Corrected cpm from reaction / [(SA of 33P-ATP in cpm/pmol) * (Reaction time in min) * (Enzyme amount in μg or mg)] * [(Reaction Volume) / (Spot Volume)]

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes